A 5"Cr release inhibition test (CRIT) 
Recently, efforts to develop herpes simplex virus (HSV) vaccines received new stimuli because of the suspected role ofthis virus in human cancer. From the point of view of safety, the most reasonable approach to the development of an HSV vaccine probably is to produce a subviral preparation, as discussed in a previous paper (3) . Rapid determination of the herpesvirus antigen content in such a preparation is one ofthe problems which the research worker faces. In our previous experiments the content of antigens reactive with antibodies neutralizing HSV was measured by a blocking neutralization test (3) .
Vasconcelos-Costa (13) and Luborsky et al. (4) (9) .
MATERIALS AND METHODS Cell cultures. Human diploid cells (LEP) and rabbit embryo fibroblasts (REF) were the same as in previous experiments (7, 10) . Both cell lines were cultivated in modified medium 199 (EPL) containing calf serum growth-active proteins (6) . LEP (2) . The blocking neutralization test was performed as described elsewhere (3 ,uCi of 5"Cr (as Na2CrO4, 106 Ci/g; Isocomerz, German Democratic Republic). After a 1-h incubation at 370C with moderate shaking, the cells were washed four times with 7 ml of medium and finally resuspended at the desired concentration.
Preparation of cryopreserved target cells for CRT. Trypsinized HSV-infected and control noninfected cells were suspended in cryoprotective medium (maintenance medium without antibiotics containing 7.5% dimethyl sulfoxide) to a final concentration of 2 x 106 cells per ml. Ampoules with cells were frozen to -250C at a rate of 1'C per min in an alcohol-solid CO2 mixture. The cells were then placed at -70'C. Before being labeled with 5"Cr, the cells were rapidly thawed in a 370C water bath and washed with medium. The subsequent procedure was the same as that for the freshly infected cells.
CRT. Test samples for CRT consisted of 0.1 ml of medium, 0.1 ml of serum dilution, 0.1 ml of complement, and 0.2 ml of 61Cr-labeled cell suspension. The reaction mixtures, prepared in Eppendorf centrifugation tubes, were continuously shaken for 90 min at room temperature and then centrifuged for 15 s in an Eppendorf 3 200 centrifuge. Volumes of 0.2 ml of the supernatants were put into ampoules, and radioactivity was measured in a Packard gamma scintillation spectrometer for 5 min. Two types of control were included in each test. In the first, serum was replaced by medium to determine spontaneous chromium release. In the second, for maximum release determination, 0.8 ml of distilled water was added to 0.2 ml of target cells, and these mixtures were subjected to three cycles of freezing and thawing. After centrifugation, 0.4 ml of supernatant was taken for radioactivity determination.
The percentage of immune lysis was calculated by the formula proposed by Brunner et al. (1) CRIT. In the 5"Cr release cytotoxicity inhibition test (CRIT), AM from HSV-infected cells was used instead of medium. Equal amounts (0.1 ml) of serum and serially diluted AM were incubated for 1 h at 37°C before the addition of complement and target cells. Thereafter, the test proceeded as described above. of the reciprocal of AM dilution against the percentage of inhibition of 51Cr release revealed a linear relation (Fig. 2) . The highest titers of HSV antigens were found with the lowest concentrations of antibody and complement. Figure 4 shows results of CRIT with freshly infected cells and cells which had been kept for 3 months at -70'C. The results are clearly comparable.
DISCUSSION
Numerous studies (e.g., 8, 11, 14) have furnished evidence that the viral antigens present on the surfaces of HSV-infected cells are the same as or similar to those of the virion surface. This information forms the basis for the quantitation of antibodies to HSV in the 5"Cr release test (5, 11) and also for the titration of solubilized HSV antigens in CRIT, as has been described in this work.
The data presented above show that the titer of HSV antigens was dependent on complement, antibody, and cell concentrations. The highest titer was found in samples containing the least In results similar to those reported by Thong et al. (12) for cytomegalovirus-infected cells, in our hands HSV-1-infected cells kept frozen at -70°C and freshly infected cells gave comparable 51Cr releases. A similar high degree of stability was found for frozen cells infected with HSV-2 (data not given). The use of cryopreserved cells in CRT and CRIT seems to facilitate highlevel reproducibility in different experiments.
Taking into consideration the simplicity, reproducibility and sensitivity of CRIT, this test may be expected to prove useful not only in studies on HSV but also in studies of other enveloped viruses.
